This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Safeguard Scientifics CEO Discusses Q3 2011 Results - Earnings Call Transcript

Safeguard Scientifics, Inc. ( SFE)

Q3 2011 Earnings Conference Call

October 26, 2011 9:00 AM ET

Executives

John Shave – VP, Business Development and Corporate Communications

Peter Boni – President and CEO

Steve Zarrilli – SVP and CFO

Analysts

Nick Halen – Sidoti & Company

Matt Dolan – Roth Capital Partners

Troy Ward – Stifel Nicolaus

Reggie Miller – CSLA

Allen Zwickler – First Manhattan

Presentation

Operator

Thank you for standing by and welcome to the Safeguard Scientifics Third Quarter 2011 Results Conference Call. At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session.

(Operator instructions)

Please be advised that the conference is being recorded today October 26, 2011. I would now like to hand the conference over to your speaker, Mr. John Shave, Vice President of Business Development and Corporate Communications. Thank you. Please go ahead.

John Shave

Good morning, and thank you for joining us for our third quarter conference call and update. Joining me on today’s call are Peter Boni, Safeguard’s Chief Executive Officer and President; and Steve Zarrilli, Senior Vice President and Chief Financial Officer.

During today’s call, Peter will review third quarter 2011 highlights and other developments and Steve will discuss Safeguard’s financial results and strategies. After that, we will open up the lines for your questions.

Before we begin, I must remind you that today’s presentation includes forward-looking statements. Reliance on forward-looking statements involve certain risks and uncertainties, including but not limited to the uncertainty of future performance of our partner companies, the risks of acquisition or disposition of interest in partner companies, capital spending by customers and the effect of regulatory and economic conditions generally, as well as the development of the life sciences and technology markets and other uncertainties that are described in our filings.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,999.14 -35.79 -0.20%
S&P 500 2,100.33 -0.07 -0.00%
NASDAQ 5,015.3120 +20.71 0.41%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs